These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12076467)

  • 21. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
    Vidal L; Ben Dor I; Paul M; Eliakim-Raz N; Pokroy E; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003992. PubMed ID: 24105485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
    Mohan P; Brocklehurst P
    Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
    Beyar-Katz O; Dickstein Y; Borok S; Vidal L; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003914. PubMed ID: 28577308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Jahnke N
    Cochrane Database Syst Rev; 2014 Apr; (4):CD002007. PubMed ID: 24788768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Robenshtok E; Shefet D; Gafter-Gvili A; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004418. PubMed ID: 18254049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
    Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
    Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
    Falagas ME; Matthaiou DK; Karveli EA; Peppas G
    Aliment Pharmacol Ther; 2007 Mar; 25(5):537-56. PubMed ID: 17305755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
    Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
    Contreras V; Sepúlveda S; Heredia A
    Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
    DeJace P; Klastersky J
    Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.
    Eliakim-Raz N; Robenshtok E; Shefet D; Gafter-Gvili A; Vidal L; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD004418. PubMed ID: 22972070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Shefet D; Robenshtock E; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004418. PubMed ID: 15846713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
    Raz-Pasteur A; Shasha D; Paul M
    Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
    Furno P; Bucaneve G; Del Favero A
    Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients.
    Ishikawa K; Nakamura T; Kawai F; Ota E; Mori N
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colony stimulating factors for chemotherapy induced febrile neutropenia.
    Clark OA; Lyman G; Castro AA; Clark LG; Djulbegovic B
    Cochrane Database Syst Rev; 2003; (3):CD003039. PubMed ID: 12917942
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.